Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumryz Preference Study in Children with Narcolepsy
NCT06809803Phase 2Recruiting
- Sponsor
- Stanford University
- Start
- Oct 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium oxybate in narcolepsy type 1 (NT1), sponsored by Stanford University. Started Oct 2025; status: recruiting.
02
Drugs
sodium oxybate
03
Conditions
narcolepsy type 1 (NT1)
Beyond the preview
Go deeper on NCT06809803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06809803.